LobbyingFoundation for Sarcoidosis Research lobbying by quarter
Foundation for Sarcoidosis Research's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q2 2024; the issues it reports most are Budget/Appropriations and Health Issues.
Foundation for Sarcoidosis Research
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2024
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$0 · 8 reports
- Health issues$0 · 8 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
No house or agency named.
Firms it paid
| Firm | ||
|---|---|---|
| Health and Medicine Counsel | $0 | 8 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DANE CHRISTIANSEN | Legislative Consultant | Q2 2026 |
| KIRA FLAHERTY | Legislative Consultant | Q2 2026 |
| PHILIP GOGLAS ii | Legislative Consultant | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Health and Medicine Counsel | Under $5,000 |
| 04/20for Q1 | Health and Medicine Counsel | Under $5,000 |
| 04/06for Q2 2024 | Health and Medicine Counsel | Under $5,000 |
| 01/16for Q4 2025 | Health and Medicine Counsel | Under $5,000 |
| 25/10/20for Q3 2025 | Health and Medicine Counsel | Under $5,000 |
| 25/07/18for Q2 2025 | Health and Medicine Counsel | Under $5,000 |
| 25/04/17for Q1 2025 | Health and Medicine Counsel | Under $5,000 |
| 25/02/04for Q4 2024 | Health and Medicine Counsel | Under $5,000 |
| 25/01/28for Q2 2024 | Health and Medicine Counsel | Under $5,000 |
| 24/11/14for Q2 2024 | Health and Medicine Counsel | Under $5,000 |
| 24/07/02for Q2 2024 | Health and Medicine Counsel | Under $5,000 |